Tepoxalin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C20H20ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TZ4OX61974, chemically known as 1h-pyrazole-3-propanamide, 5-(4-chlorophenyl)-n-hydroxy-1-(4-methoxyphenyl)-n-methyl- but generally known as tepoxalin, which bears US NIH Compound Identifier 59757. European Medicines Agency schedules Tepoxalin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10905MIG. The term TEPOXALIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). TEPOXALIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tepoxalin under HS 29331990 and SITC 51571. As of Q4 2014, TEPOXALIN remains the US FDA Preferred Term for this commodity. Tepoxalin bears US NLM identifiers UMLS ID C0145162 and NCI Concept Code C76817. SMILES: CLC1CCC(C2N(NC(CCC(=O)N(O)C)C2)C2CCC(OC)CC2)CC1.